Dr. Kendra V. Johnson is a Technical Advisor at Leason Ellis and a member of the Patent Practice Group. Kendra supports patent preparation and prosecution for life sciences clients. She has expertise in pharmaceutical formulations, small molecule pharmaceuticals, antibodies, CAR T cells, and diagnostic and therapeutic methods in molecular and cellular biology.
Kendra holds a Ph.D. in Pathobiology and Mechanisms of Disease from Columbia University, where her graduate research focused on uncovering regulatory pathways involved in retinal vasculature development. She became interested in intellectual property through a fellowship at Columbia University Technology Ventures, where she evaluated technologies developed at the university.
Peer-Reviewed Publications